1. 016 Development of a High-Throughput, Cell-Based Assay for Anti-Myofibroblast Activity in Peyronie's Disease. (1st May 2016) Authors: Mateus, M.; Stebbeds, W.; Ameyaw, B.; Raheem, A.; Spilotros, M.; Garraffa, G.; Muneer, A.; Christopher, N.; Cellek, S.; Ralph, D. Journal: Journal of sexual medicine Issue: Volume 13(2016)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of multiparametric kinetic measurements and analytics workflows for the generation of an IPSC derived cardiomyocyte based cardiovascular model. (September 2021) Authors: Raniga, K.; Stebbeds, W.; Denning, C. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. HP-01-001 Development of Secondary Assays to Validate Hits from Primary Phenotypic Screen for Anti-Myofibroblast Activity in Peyronie's Disease. (1st April 2017) Authors: Ilg, M.; Mateus, M.; Stebbeds, W.; Raheem, A.; Capece, M.; Parnham, A.; Garaffa, G.; Muneer, A.; Christopher, N.; Cellek, S.; Ralph, D. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 4a Page Start: e142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prediction of inotropic effect based on calcium transients in human iPSC-derived cardiomyocytes using novel waveform parameters and a modified random forest algorithm. (September 2021) Authors: Yang, H.; Obrezanova, O.; Pointon, A.; Stebbeds, W.; Francis, J.; Beattie, K.A.; Clements, P.; Harvey, J.S.; Smith, G.F.; Bender, A. Journal: Toxicology letters Issue: Volume 350(2021)Supplement Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PS-04-001 Further Validation of Phenotypic High-Throughput, Cell-Based Assay for Anti-Myofibroblast Activity in Peyronie's Disease. (1st April 2017) Authors: Ilg, M.; Mateus, M.; Stebbeds, W.; Raheem, A.; Capece, M.; Paranham, A.; Garaffa, G.; Muneer, A.; Christopher, N.; Cellek, S.; Ralph, D. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 4a Page Start: e116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PS-04-003 Vardenafil, Tamoxifen and their Combination can Prevent but not Reverse TGF-beta1-induced Myofibroblast Transformation of TA-derived Cells. (1st May 2019) Authors: Ilg, M.; Stebbeds, W.; Parnham, A.; Garaffa, G.; Muneer, A.; Christopher, N.; Cellek, S.; Ralph, D. Journal: Journal of sexual medicine Issue: Volume 16(2019)Supplement 2 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. PS-04-004 First Results from a Novel Cell-Based Assay for Anti-Myofibroblast Activity in Peyronie's Disease. (1st May 2016) Authors: Mateus, M.; Stebbeds, W.; Ameyaw, B.; Raheem, A.; Spilotros, M.; Garaffa, G.; Muneer, A.; Christopher, N.; Cellek, S.; Ralph, D. Journal: Journal of sexual medicine Issue: Volume 13(2016)Supplement 2 Page Start: S89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗